composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica
composto inibidor da di-hidro-orotato desidrogenase, formulação farmacêutica, e, uso de um composto ou de uma formulação farmacêutica. inibidores da enzima da di-hidro-orotato desidrogenase (dhod) parasítica são terapêuticos candidatos para tratar a malária. ilustrativo de tais agentes terapêuticos...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Jeremy Burrows David Floyd Pradipsinh K. Rathod David Matthews Ramesh Gujjar Susan A. Charman Jose Coteron-Lopez ALKA MARWAHA Margaret Phillips |
| description | composto inibidor da di-hidro-orotato desidrogenase, formulação farmacêutica, e, uso de um composto ou de uma formulação farmacêutica. inibidores da enzima da di-hidro-orotato desidrogenase (dhod) parasítica são terapêuticos candidatos para tratar a malária. ilustrativo de tais agentes terapêuticos incluem o composto: e uma classe de triazolopiridina de composto que se conformam com a fórmula ix: e seus solvatos, estereoisômeros, tautômeros e sais farmaceuticamente aceitáveis.
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112012007179B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112012007179B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112012007179B13</originalsourceid><addsrcrecordid>eNrjZAhKzs8tyC8uyVfIzMtMykzJL1JISVRIydTNyEwpytfNL8ovSQRKpqQWg_jpqXmJxak6CkCUll-UW5qTeHj54cX5CmmJRbmJyYdXlZZkJifyMLCmJeYUp_JCaW4GVTfXEGcP3dSC_PjU4oLE5NS81JJ4pyBDQyMDIDIwNzS3dDI0JlYdAL5wO7M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica</title><source>esp@cenet</source><creator>Jeremy Burrows ; David Floyd ; Pradipsinh K. Rathod ; David Matthews ; Ramesh Gujjar ; Susan A. Charman ; Jose Coteron-Lopez ; ALKA MARWAHA ; Margaret Phillips</creator><creatorcontrib>Jeremy Burrows ; David Floyd ; Pradipsinh K. Rathod ; David Matthews ; Ramesh Gujjar ; Susan A. Charman ; Jose Coteron-Lopez ; ALKA MARWAHA ; Margaret Phillips</creatorcontrib><description>composto inibidor da di-hidro-orotato desidrogenase, formulação farmacêutica, e, uso de um composto ou de uma formulação farmacêutica. inibidores da enzima da di-hidro-orotato desidrogenase (dhod) parasítica são terapêuticos candidatos para tratar a malária. ilustrativo de tais agentes terapêuticos incluem o composto: e uma classe de triazolopiridina de composto que se conformam com a fórmula ix: e seus solvatos, estereoisômeros, tautômeros e sais farmaceuticamente aceitáveis.
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201201&DB=EPODOC&CC=BR&NR=112012007179B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201201&DB=EPODOC&CC=BR&NR=112012007179B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Jeremy Burrows</creatorcontrib><creatorcontrib>David Floyd</creatorcontrib><creatorcontrib>Pradipsinh K. Rathod</creatorcontrib><creatorcontrib>David Matthews</creatorcontrib><creatorcontrib>Ramesh Gujjar</creatorcontrib><creatorcontrib>Susan A. Charman</creatorcontrib><creatorcontrib>Jose Coteron-Lopez</creatorcontrib><creatorcontrib>ALKA MARWAHA</creatorcontrib><creatorcontrib>Margaret Phillips</creatorcontrib><title>composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica</title><description>composto inibidor da di-hidro-orotato desidrogenase, formulação farmacêutica, e, uso de um composto ou de uma formulação farmacêutica. inibidores da enzima da di-hidro-orotato desidrogenase (dhod) parasítica são terapêuticos candidatos para tratar a malária. ilustrativo de tais agentes terapêuticos incluem o composto: e uma classe de triazolopiridina de composto que se conformam com a fórmula ix: e seus solvatos, estereoisômeros, tautômeros e sais farmaceuticamente aceitáveis.
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAhKzs8tyC8uyVfIzMtMykzJL1JISVRIydTNyEwpytfNL8ovSQRKpqQWg_jpqXmJxak6CkCUll-UW5qTeHj54cX5CmmJRbmJyYdXlZZkJifyMLCmJeYUp_JCaW4GVTfXEGcP3dSC_PjU4oLE5NS81JJ4pyBDQyMDIDIwNzS3dDI0JlYdAL5wO7M</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Jeremy Burrows</creator><creator>David Floyd</creator><creator>Pradipsinh K. Rathod</creator><creator>David Matthews</creator><creator>Ramesh Gujjar</creator><creator>Susan A. Charman</creator><creator>Jose Coteron-Lopez</creator><creator>ALKA MARWAHA</creator><creator>Margaret Phillips</creator><scope>EVB</scope></search><sort><creationdate>20201201</creationdate><title>composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica</title><author>Jeremy Burrows ; David Floyd ; Pradipsinh K. Rathod ; David Matthews ; Ramesh Gujjar ; Susan A. Charman ; Jose Coteron-Lopez ; ALKA MARWAHA ; Margaret Phillips</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112012007179B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Jeremy Burrows</creatorcontrib><creatorcontrib>David Floyd</creatorcontrib><creatorcontrib>Pradipsinh K. Rathod</creatorcontrib><creatorcontrib>David Matthews</creatorcontrib><creatorcontrib>Ramesh Gujjar</creatorcontrib><creatorcontrib>Susan A. Charman</creatorcontrib><creatorcontrib>Jose Coteron-Lopez</creatorcontrib><creatorcontrib>ALKA MARWAHA</creatorcontrib><creatorcontrib>Margaret Phillips</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Jeremy Burrows</au><au>David Floyd</au><au>Pradipsinh K. Rathod</au><au>David Matthews</au><au>Ramesh Gujjar</au><au>Susan A. Charman</au><au>Jose Coteron-Lopez</au><au>ALKA MARWAHA</au><au>Margaret Phillips</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica</title><date>2020-12-01</date><risdate>2020</risdate><abstract>composto inibidor da di-hidro-orotato desidrogenase, formulação farmacêutica, e, uso de um composto ou de uma formulação farmacêutica. inibidores da enzima da di-hidro-orotato desidrogenase (dhod) parasítica são terapêuticos candidatos para tratar a malária. ilustrativo de tais agentes terapêuticos incluem o composto: e uma classe de triazolopiridina de composto que se conformam com a fórmula ix: e seus solvatos, estereoisômeros, tautômeros e sais farmaceuticamente aceitáveis.
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112012007179B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | composto inibidor da di-hidro-orotato desidrogenase, e, formulação farmacêutica |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A18%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Jeremy%20Burrows&rft.date=2020-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112012007179B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |